• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经病理突触标志物 NPTX2 在 DLB 患者脑脊液中的水平降低与 α-突触核蛋白和 VGF 水平相关。

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF.

机构信息

Neurochemistry Department, Clinical Chemistry, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands.

Department of Neurology, Alzheimer Center Amsterdam, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands.

出版信息

Cells. 2020 Dec 29;10(1):38. doi: 10.3390/cells10010038.

DOI:10.3390/cells10010038
PMID:33383752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7824459/
Abstract

Dementia with Lewy bodies (DLB) is a neurodegenerative disease where synaptic loss and reduced synaptic integrity are important neuropathological substrates. Neuronal Pentraxin 2(NPTX2) is a synaptic protein that drives the GABAergic inhibitory circuit. Our aim was to examine if NPTX2 cerebral spinal fluid (CSF) levels in DLB patients were altered and how these levels related to other synaptic protein levels and to cognitive function and decline. NPTX2, VGF, and α-synuclein levels were determined in CSF of cognitive healthy ( = 27), DLB ( = 48), and AD ( = 20) subjects. Multiple cognitive domains were tested, and data were compared using linear models. Decreased NPTX2 levels were observed in DLB (median = 474) and AD (median = 453) compared to cognitive healthy subjects (median = 773). Strong correlations between NPTX2, VGF, and α-synuclein were observed dependent on diagnosis. Combined, these markers had a high differentiating power between DLB and cognitive healthy subjects (AUC = 0.944). Clinically, NPTX2 levels related to global cognitive function and cognitive decline in the visual spatial domain. NPTX2 CSF levels were reduced in DLB and closely correlated to decreased VGF and α-synuclein CSF levels. CSF NPTX2 levels in DLB related to decreased functioning in the visual spatial domain.

摘要

路易体痴呆(DLB)是一种神经退行性疾病,突触丧失和突触完整性降低是重要的神经病理学基础。神经元五聚素 2(NPTX2)是一种驱动 GABA 能抑制回路的突触蛋白。我们的目的是研究 DLB 患者的 NPTX2 脑脊液(CSF)水平是否发生改变,以及这些水平与其他突触蛋白水平以及认知功能和下降的关系。 在认知健康者(=27)、DLB(=48)和 AD(=20)受试者的 CSF 中测定了 NPTX2、VGF 和 α-突触核蛋白的水平。对多个认知领域进行了测试,并使用线性模型比较了数据。与认知健康者(中位数=773)相比,DLB(中位数=474)和 AD(中位数=453)的 NPTX2 水平降低。观察到 NPTX2、VGF 和 α-突触核蛋白之间存在强相关性,与诊断有关。这些标志物联合具有区分 DLB 和认知健康者的高区分能力(AUC=0.944)。临床上,NPTX2 水平与整体认知功能和视觉空间域的认知下降有关。DLB 患者的 CSF NPTX2 水平降低,与 VGF 和 α-突触核蛋白 CSF 水平降低密切相关。DLB 患者的 CSF NPTX2 水平与视觉空间域功能下降有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0a/7824459/593bd7f62972/cells-10-00038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0a/7824459/593bd7f62972/cells-10-00038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0a/7824459/593bd7f62972/cells-10-00038-g001.jpg

相似文献

1
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF.神经病理突触标志物 NPTX2 在 DLB 患者脑脊液中的水平降低与 α-突触核蛋白和 VGF 水平相关。
Cells. 2020 Dec 29;10(1):38. doi: 10.3390/cells10010038.
2
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies.路易体痴呆患者脑脊液中的 VGF 肽。
Int J Mol Sci. 2019 Sep 20;20(19):4674. doi: 10.3390/ijms20194674.
3
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach.路易体痴呆新型脑脊液生物标志物候选物的鉴定:蛋白质组学方法
Mol Neurodegener. 2020 Jun 18;15(1):36. doi: 10.1186/s13024-020-00388-2.
4
Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease.正常对照、轻度认知障碍和阿尔茨海默病患者的脑脊液α-突触核蛋白与路易小体样症状
J Alzheimers Dis. 2015;43(3):1007-16. doi: 10.3233/JAD-141287.
5
Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.帕金森病、路易体痴呆或其他神经退行性疾病患者的脑脊液中α-突触核蛋白、淀粉样β、tau、磷酸化 tau 和神经元特异性烯醇化酶水平:与认知和核医学成像结果的关系。
Neurosci Lett. 2020 Jan 10;715:134564. doi: 10.1016/j.neulet.2019.134564. Epub 2019 Nov 13.
6
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome.脑脊液中 NPTX2 谱支持阿尔茨海默病相关抑制回路功能障碍在唐氏综合征成人中的作用。
Mol Neurodegener. 2020 Aug 17;15(1):46. doi: 10.1186/s13024-020-00398-0.
7
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.脑脊液脂肪酸结合蛋白 3、α-突触核蛋白与阿尔茨海默病核心生物标志物在路易体疾病和阿尔茨海默病痴呆中的差异作用。
Alzheimers Res Ther. 2017 Jul 28;9(1):52. doi: 10.1186/s13195-017-0276-4.
8
CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease.脑脊液 α-突触核蛋白不能区分路易体痴呆与阿尔茨海默病。
J Alzheimers Dis. 2010;22(1):87-95. doi: 10.3233/JAD-2010-100186.
9
Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice.脑脊液α-突触核蛋白有助于提高临床实践中路易体痴呆和阿尔茨海默病的鉴别诊断能力。
Int J Mol Sci. 2022 Nov 4;23(21):13488. doi: 10.3390/ijms232113488.
10
Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.帕金森病痴呆、路易体痴呆和阿尔茨海默病患者的神经精神症状和 α-突触核蛋白特征。
J Neurol. 2018 Oct;265(10):2295-2301. doi: 10.1007/s00415-018-8992-7. Epub 2018 Aug 6.

引用本文的文献

1
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome.一种用于阿尔茨海默病和唐氏综合征中NPTX2的新型单分子阵列检测方法的开发与验证
Alzheimers Dement. 2025 Jun;21(6):e70241. doi: 10.1002/alz.70241.
2
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.脑脊液蛋白质组的大规模网络分析确定了额颞叶痴呆的分子特征。
Nat Aging. 2025 May 16. doi: 10.1038/s43587-025-00878-2.
3
Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer's pathophysiological biomarkers.

本文引用的文献

1
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome.脑脊液中 NPTX2 谱支持阿尔茨海默病相关抑制回路功能障碍在唐氏综合征成人中的作用。
Mol Neurodegener. 2020 Aug 17;15(1):46. doi: 10.1186/s13024-020-00398-0.
2
Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson's Disease Patients and Is Present within Lewy Bodies.接触蛋白-1 在帕金森病患者脑脊液中减少,并存在于路易小体中。
Biomolecules. 2020 Aug 12;10(8):1177. doi: 10.3390/biom10081177.
3
Multiscale causal networks identify VGF as a key regulator of Alzheimer's disease.
在按阿尔茨海默病病理生理学生物标志物分层的路易体痴呆临床队列中评估脑脊液中VAMP-2和SNAP-25的水平。
Alzheimers Res Ther. 2025 Feb 24;17(1):51. doi: 10.1186/s13195-025-01685-y.
4
Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases.解决神经退行性疾病中脑源性蛋白质脑脊液水平的个体间差异。
Sci Rep. 2025 Jan 3;15(1):668. doi: 10.1038/s41598-024-83281-y.
5
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's disease.新发帕金森病纵向脑脊液中的溶酶体和突触功能障碍标志物
NPJ Parkinsons Dis. 2024 May 17;10(1):102. doi: 10.1038/s41531-024-00714-1.
6
Biofluid biomarkers for Alzheimer's disease.用于阿尔茨海默病的生物流体生物标志物。
Front Aging Neurosci. 2024 Apr 10;16:1380237. doi: 10.3389/fnagi.2024.1380237. eCollection 2024.
7
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.脑脊液蛋白质组的大规模网络分析确定了额颞叶痴呆的分子特征。
Res Sq. 2024 Mar 28:rs.3.rs-4103685. doi: 10.21203/rs.3.rs-4103685/v1.
8
Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis.在一项为期3年的回顾性分析中,血清神经丝轻链蛋白(NFL)和tau蛋白与谵妄相关,但血清泛素羧基末端水解酶L1(UCHL-1)和胶质纤维酸性蛋白(GFAP)或脑脊液中的突触结合蛋白25(SNAP-25)、神经元五肽2(NPTX2)或可溶性触发受体表达于髓细胞2(sTREM2)与谵妄不相关。
Front Neurol. 2024 Mar 19;15:1356575. doi: 10.3389/fneur.2024.1356575. eCollection 2024.
9
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases.用于广泛神经退行性疾病中突触功能障碍的脑脊液生物标志物谱。
Brain. 2024 Jul 5;147(7):2414-2427. doi: 10.1093/brain/awae032.
10
How should we be using biomarkers in trials of disease modification in Parkinson's disease?我们应该如何在帕金森病疾病修饰治疗的临床试验中使用生物标志物?
Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265.
多尺度因果网络确定 VGF 为阿尔茨海默病的关键调节因子。
Nat Commun. 2020 Aug 7;11(1):3942. doi: 10.1038/s41467-020-17405-z.
4
Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study.认知测试有助于临床区分阿尔茨海默病与路易体痴呆:来自病理研究的证据。
Alzheimers Dement. 2020 Aug;16(8):1173-1181. doi: 10.1002/alz.12120. Epub 2020 Jun 19.
5
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach.路易体痴呆新型脑脊液生物标志物候选物的鉴定:蛋白质组学方法
Mol Neurodegener. 2020 Jun 18;15(1):36. doi: 10.1186/s13024-020-00388-2.
6
Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders: A Meta-analysis.α-突触核蛋白水平在路易体痴呆与其他神经退行性疾病鉴别诊断中的作用:一项荟萃分析。
Alzheimer Dis Assoc Disord. 2020 Jul-Sep;34(3):220-224. doi: 10.1097/WAD.0000000000000381.
7
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies.性别特异性与路易体痴呆症患者脑脊液生物标志物的相关性。
Alzheimers Res Ther. 2020 Apr 17;12(1):44. doi: 10.1186/s13195-020-00610-9.
8
CSF α-synuclein correlates with CSF neurogranin in late-life depression.脑脊液 α-突触核蛋白与老年期抑郁症的脑脊液神经颗粒蛋白相关。
Int J Neurosci. 2021 Apr;131(4):357-361. doi: 10.1080/00207454.2020.1744596. Epub 2020 Mar 31.
9
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease.阿尔茨海默病脑脊液和血液生物标志物的最新进展
Ther Adv Neurol Disord. 2019 Dec 18;12:1756286419888819. doi: 10.1177/1756286419888819. eCollection 2019.
10
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease.脑脊液中的突触生物标志物有助于诊断,与认知相关,并可预测轻度认知障碍和阿尔茨海默病的进展。
Alzheimers Dement (N Y). 2019 Dec 9;5:871-882. doi: 10.1016/j.trci.2019.11.002. eCollection 2019.